Bain Capital Life Sciences Investors, LLC Long-Term Concentrated

Location: Boston, MA

CIK: 0001703031 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value: $1.612B (100.0% shares, 0.0% debt)

Holdings (33)

— SPRINGWORKS THERAPEUTICS INC 19.0%

Value $306M Shares 4,831,307 Est. Cost $21.68 Unrealized —

— DYNAVAX TECHNOLOGIES CORP 10.0%

Value $162M Shares 8,415,000 Est. Cost $9.83 Unrealized —

RPID RAPID MICRO BIOSYSTEMS INC 9.7%

Value $156M Shares 8,434,560 Est. Cost $20.66 Unrealized 0.0%

AVIR ATEA PHARMACEUTICALS INC 8.0%

Value $130M Shares 3,700,000 Est. Cost $32.23 Unrealized -14.0%

IVVD ADAGIO THERAPEUTICS INC 6.5%

Value $105M Shares 2,487,207 Est. Cost $37.11 Unrealized 0.0%

ARQT ARCUTIS BIOTHERAPEUTICS INC. 5.9%

Value $95.06M Shares 3,979,292 Est. Cost $26.87 Unrealized -15.1%

NUVL NUVALENT INC 4.8%

Value $77.3M Shares 3,428,014 Est. Cost $29.01 Unrealized 0.0%

CCCC C4 THERAPEUTICS INC 4.6%

Value $73.37M Shares 1,642,209 Est. Cost $29.00 Unrealized +47.7%

— DICERNA PHARMACEUTICALS INC 3.9%

Value $62.1M Shares 3,080,237 Est. Cost $9.03 Unrealized —

ANNX ANNEXON INC 3.7%

Value $60.33M Shares 3,241,628 Est. Cost $23.46 Unrealized -13.5%

PHVS PHARVARIS N V 3.5%

Value $56.39M Shares 3,180,601 Est. Cost $31.46 Unrealized -45.6%

NRIX NURIX THERAPEUTICS INC 2.4%

Value $38.48M Shares 1,284,314 Est. Cost $25.20 Unrealized +22.5%

CRNX CRINETICS PHARMACEUTICALS 2.2%

Value $35.36M Shares 1,679,701 Est. Cost $17.24 Unrealized +21.4%

— MERSANA THERAPEUTICS INC. 2.2%

Value $34.85M Shares 3,695,667 Est. Cost $22.91 Unrealized —

— SYROS PHARMACEUTICALS INC 1.6%

Value $25.86M Shares 5,785,036 Est. Cost $10.85 Unrealized —

TNGX TANGO THERAPEUTICS INC 1.5%

Value $24.85M Shares 1,921,790 Est. Cost $11.99 Unrealized 0.0%

— AEGLEA BIO THERAPEUTICS INC 1.4%

Value $22.64M Shares 2,847,689 Est. Cost $9.18 Unrealized —

— APTINYX INC 1.3%

Value $20.81M Shares 8,891,758 Est. Cost $8.16 Unrealized —

— SOLID BIOSCIENCES INC 1.2%

Value $18.95M Shares 7,929,918 Est. Cost $7.99 Unrealized —

— MARINUS PHARMACEUTICALS INC 1.0%

Value $16.29M Shares 1,431,058 Est. Cost $15.48 Unrealized —

SVRA SAVARA INC 1.0%

Value $16.04M Shares 11,622,598 Est. Cost $1.49 Unrealized -9.2%

NAUT NAUTILUS BIOTECHNOLOGY INC 0.8%

Value $12.28M Shares 2,000,000 Est. Cost $10.83 Unrealized -26.4%

— X4 PHARMACEUTICALS INC 0.7%

Value $11.21M Shares 2,119,540 Est. Cost $10.24 Unrealized —

— RESEARCH ALLIANCE CORP II 0.6%

Value $9.85M Shares 1,000,000 Est. Cost $10.25 Unrealized —

— BLUEBIRD BIO INC 0.4%

Value $7.239M Shares 538,179 Est. Cost $30.15 Unrealized —

— ARYA SCIENCES ACQU CORP IV 0.4%

Value $7.035M Shares 700,000 Est. Cost $10.47 Unrealized —

— ARYA SCIENCES ACQUISITN CORP 0.3%

Value $4.94M Shares 500,000 Est. Cost $9.88 Unrealized —

— PANACEA ACQUISITION CORP II 0.3%

Value $4.885M Shares 500,000 Est. Cost $10.02 Unrealized —

— BCLS ACQUISITION CORP 0.3%

Value $4.856M Shares 487,500 Est. Cost $11.14 Unrealized —

— OMEGA ALPHA SPAC 0.2%

Value $3.894M Shares 400,000 Est. Cost $9.90 Unrealized —

— FRAZIER LIFESCIENCES ACQU CO 0.2%

Value $3.009M Shares 300,000 Est. Cost $10.38 Unrealized —

— JIYA ACQUISITION CORP 0.2%

Value $2.925M Shares 300,000 Est. Cost $10.30 Unrealized —

MLTX HELIX ACQUISITION CORP 0.2%

Value $2.488M Shares 250,000 Est. Cost $11.37 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	SPRINGWORKS THERAPEUTICS INC	4,831,307	$306M	19.0%	$21.68	—	COM	85205L107
—	DYNAVAX TECHNOLOGIES CORP	8,415,000	$162M	10.0%	$9.83	—	COM NEW	268158201
RPID	RAPID MICRO BIOSYSTEMS INC	8,434,560	$156M	9.7%	$20.66	0.0%	CLASS A COM	75340L104
AVIR	ATEA PHARMACEUTICALS INC	3,700,000	$130M	8.0%	$32.23	-14.0%	COM	04683R106
IVVD	ADAGIO THERAPEUTICS INC	2,487,207	$105M	6.5%	$37.11	0.0%	COM	00534A102
ARQT	ARCUTIS BIOTHERAPEUTICS INC.	3,979,292	$95.06M	5.9%	$26.87	-15.1%	COM	03969K108
NUVL	NUVALENT INC	3,428,014	$77.3M	4.8%	$29.01	0.0%	COM	670703107
CCCC	C4 THERAPEUTICS INC	1,642,209	$73.37M	4.6%	$29.00	+47.7%	COM STK	12529R107
—	DICERNA PHARMACEUTICALS INC	3,080,237	$62.1M	3.9%	$9.03	—	COM	253031108
ANNX	ANNEXON INC	3,241,628	$60.33M	3.7%	$23.46	-13.5%	COM	03589W102
PHVS	PHARVARIS N V	3,180,601	$56.39M	3.5%	$31.46	-45.6%	COM	N69605108
NRIX	NURIX THERAPEUTICS INC	1,284,314	$38.48M	2.4%	$25.20	+22.5%	COM	67080M103
CRNX	CRINETICS PHARMACEUTICALS	1,679,701	$35.36M	2.2%	$17.24	+21.4%	COM	22663K107
—	MERSANA THERAPEUTICS INC.	3,695,667	$34.85M	2.2%	$22.91	—	COM	59045L106
—	SYROS PHARMACEUTICALS INC	5,785,036	$25.86M	1.6%	$10.85	—	COM	87184Q107
TNGX	TANGO THERAPEUTICS INC	1,921,790	$24.85M	1.5%	$11.99	0.0%	COM	87583X109
—	AEGLEA BIO THERAPEUTICS INC	2,847,689	$22.64M	1.4%	$9.18	—	COM	00773J103
—	APTINYX INC	8,891,758	$20.81M	1.3%	$8.16	—	COM	03836N103
—	SOLID BIOSCIENCES INC	7,929,918	$18.95M	1.2%	$7.99	—	COM	83422E105
—	MARINUS PHARMACEUTICALS INC	1,431,058	$16.29M	1.0%	$15.48	—	COM NEW	56854Q200
SVRA	SAVARA INC	11,622,598	$16.04M	1.0%	$1.49	-9.2%	COM	805111101
NAUT	NAUTILUS BIOTECHNOLOGY INC	2,000,000	$12.28M	0.8%	$10.83	-26.4%	COM	63909J108
—	X4 PHARMACEUTICALS INC	2,119,540	$11.21M	0.7%	$10.24	—	COM	98420X103
—	RESEARCH ALLIANCE CORP II	1,000,000	$9.85M	0.6%	$10.25	—	COM CL A	760873109
—	BLUEBIRD BIO INC	538,179	$7.239M	0.4%	$30.15	—	COM	09609G100
—	ARYA SCIENCES ACQU CORP IV	700,000	$7.035M	0.4%	$10.47	—	CL A	G31659108
—	ARYA SCIENCES ACQUISITN CORP	500,000	$4.94M	0.3%	$9.88	—	CLASS A ORD SHS	G31658100
—	PANACEA ACQUISITION CORP II	500,000	$4.885M	0.3%	$10.02	—	CL A SHS	G6882C106
—	BCLS ACQUISITION CORP	487,500	$4.856M	0.3%	$11.14	—	COM CL A	G0904B105
—	OMEGA ALPHA SPAC	400,000	$3.894M	0.2%	$9.90	—	CL A	G6749V107
—	FRAZIER LIFESCIENCES ACQU CO	300,000	$3.009M	0.2%	$10.38	—	UNIT 12/09/2025	G3710A121
—	JIYA ACQUISITION CORP	300,000	$2.925M	0.2%	$10.30	—	COM CL A	47760M102
MLTX	HELIX ACQUISITION CORP	250,000	$2.488M	0.2%	$11.37	—	COM CL A	G4444C102